Insmed Incorporated (FRA:IM8N)
140.00
+11.00 (8.53%)
Last updated: Feb 20, 2026, 4:55 PM CET
Insmed Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 510.45 | 555.03 | 482.37 | 1,074 | 716.78 |
Short-Term Investments | 919.6 | 878.8 | 298.07 | 74.24 | - |
Cash & Short-Term Investments | 1,430 | 1,434 | 780.45 | 1,148 | 716.78 |
Cash Growth | -0.26% | 83.72% | -32.03% | 60.20% | 34.54% |
Receivables | 140.86 | 52.01 | 41.19 | 29.71 | 24.35 |
Inventory | 132.07 | 98.58 | 83.25 | 69.92 | 67.01 |
Prepaid Expenses | 91.24 | 37.25 | 24.18 | 25.47 | 28.9 |
Total Current Assets | 1,794 | 1,622 | 929.06 | 1,273 | 837.04 |
Property, Plant & Equipment | 139.21 | 115.58 | 104.39 | 102.08 | 95.52 |
Long-Term Investments | - | - | - | - | 50.04 |
Goodwill | 136.11 | 136.11 | 136.11 | 136.11 | 136.11 |
Other Intangible Assets | 74.61 | 30.76 | 30.97 | 31.17 | 31.37 |
Long-Term Deferred Charges | 23.04 | 27.89 | 32.74 | 37.59 | 42.44 |
Other Long-Term Assets | 97.38 | 93.23 | 96.57 | 76.1 | 50.99 |
Total Assets | 2,265 | 2,025 | 1,330 | 1,656 | 1,244 |
Accounts Payable | 79.91 | 73.03 | 65.39 | 50.46 | 35.78 |
Accrued Expenses | 303.35 | 187.48 | 128.21 | 108.01 | 81.64 |
Current Portion of Leases | 12.81 | 12.32 | 10.64 | 8.13 | 10.14 |
Other Current Liabilities | 72.8 | 24.7 | 21.39 | 23.64 | 7.6 |
Total Current Liabilities | 468.87 | 297.53 | 225.63 | 190.24 | 135.17 |
Long-Term Debt | 703.83 | 1,264 | 1,310 | 1,273 | 566.59 |
Long-Term Leases | 32.89 | 33.18 | 38.04 | 44.49 | 35.54 |
Other Long-Term Liabilities | 319.99 | 144.7 | 87.75 | 60.49 | 95.74 |
Total Liabilities | 1,526 | 1,740 | 1,662 | 1,568 | 833.04 |
Common Stock | 2.14 | 1.79 | 1.48 | 1.36 | 1.19 |
Additional Paid-In Capital | 6,372 | 4,646 | 3,113 | 2,782 | 2,674 |
Retained Earnings | -5,637 | -4,360 | -3,446 | -2,697 | -2,265 |
Comprehensive Income & Other | 1.46 | -2.29 | -0.75 | 0.76 | 0.97 |
Shareholders' Equity | 738.98 | 285.38 | -331.92 | 87.95 | 410.47 |
Total Liabilities & Equity | 2,265 | 2,025 | 1,330 | 1,656 | 1,244 |
Total Debt | 749.54 | 1,310 | 1,359 | 1,326 | 612.27 |
Net Cash (Debt) | 680.51 | 123.88 | -578.58 | -177.6 | 154.56 |
Net Cash Growth | 449.32% | - | - | - | 20.83% |
Net Cash Per Share | 3.42 | 0.76 | -4.12 | -1.44 | 1.38 |
Filing Date Shares Outstanding | 215.55 | 181 | 148.49 | 136.41 | 118.9 |
Total Common Shares Outstanding | 214.26 | 179.38 | 147.98 | 135.65 | 118.74 |
Working Capital | 1,325 | 1,324 | 703.43 | 1,083 | 701.87 |
Book Value Per Share | 3.45 | 1.59 | -2.24 | 0.65 | 3.46 |
Tangible Book Value | 528.25 | 118.51 | -499 | -79.33 | 242.99 |
Tangible Book Value Per Share | 2.47 | 0.66 | -3.37 | -0.58 | 2.05 |
Land | 1.96 | - | - | - | - |
Buildings | 10.44 | - | - | - | - |
Machinery | 55.49 | 41.17 | 36.51 | 29.35 | 26.16 |
Construction In Progress | 42.41 | 51.13 | 35.45 | 29.53 | 27.78 |
Leasehold Improvements | 53.4 | 38.06 | 38.05 | 37.06 | 36.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.